PR
Prelude
PRTX·NASDAQWilmington DEFounded 201680 employees
Small CapbiotechPublicOncology
Platform: CDK9 Epigen
Market Cap
$0.3B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (PRTX)
Loading PRTX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpasacituzumab | PRT-563 | Phase 3 | 3 | EGFR | RBBladder Ca | ||
| Datofutibatinib | PRT-4605 | Approved | 1 | GLP-1R | ALSGBM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)